Shuttle Pharmaceuticals is Drug Discovery in United States that focus on tissue radiation protectors business. Founded in 2012. They cover business area such as owner, operator, efficacy, quality, life, cancer patient, radiation therapy, develop drug, radiation sensitizer, normal tissue radiation protector, clinical response, treatment, development, novel small molecule, ionize radiation, cancer cell, effective service.
2012
( 12 years old in 2024 )
Tissue Radiation Protectors
-
1 Research Court
Suite 450
Rockville, MD 20850
United States
Private
owneroperatorefficacyqualitylifecancer patientradiation therapydevelop drugradiation sensitizernormal tissue radiation protectorclinical responsetreatmentdevelopmentnovel small moleculeionize radiationcancer celleffective service
* We use standard office opening hours in near Shuttle Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Shuttle Pharmaceuticals is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), Shuttle Pharmaceuticals business is focusing on Tissue Radiation Protectors.
Shuttle Pharmaceuticals headquarter office and corporate office address is located in 1 Research Court Suite 450 Rockville, MD 20850 United States.
Shuttle Pharmaceuticals was founded in United States.
In 2024, Shuttle Pharmaceuticals is currently focus on tissue radiation protectors sector.
Above is snippet of Google Trends for "tissue radiation protectors" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Shuttle Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
